CACI Chair of the Board Awarded $281K in Stock and RSUs
CACI INTERNATIONAL INC /DE/
Subscribe to track CACI
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
CACI Chair Awarded $281K in Stock & RSUs
Company: CACI INTERNATIONAL INC /DE/ (CACI) Form: 4 | Filed: 2025-10-20 Significance: Low
Insider: DISBROW LISA S Title: Chair of the Board | Relationship: Director
Transaction: • Type: Grant (Annual Retainer) • Shares: 53 Common Stock + 492 RSUs • Price: $0.00 (Grant) • Value: ~$281,052 • Owned After: 1,987 Common Shares
Key Insight: Routine annual equity compensation for the Chair of the Board. The total value represents less than 0.003% of CACI's $11.34B market cap, indicating a low-significance event.
Market Context: This is a standard governance practice to align director and shareholder interests. The dilution impact from these grants is negligible.
Comprehensive Analysis
SEC Filing Analysis: CACI INTERNATIONAL INC /DE/ (CACI)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chair of the Board, Lisa S. Disbrow, received routine annual equity compensation totaling approximately $281,052 in the form of common stock and Restricted Stock Units (RSUs).
- Market Impact: This transaction is considered immaterial given the company's $11.34 billion market capitalization and is unlikely to influence the stock price.
Company Information
| Field | Value |
|---|---|
| Company | CACI INTERNATIONAL INC /DE/ |
| Ticker Symbol | CACI |
| CIK | 0000016058 |
| Industry | Services-Computer Integrated Systems Design |
Insider Information
| Field | Value |
|---|---|
| Name | DISBROW LISA S |
| CIK | 0001712360 |
| Title/Position | Chair of the Board |
| Relationship | Director |
Transaction Details
This filing reported two grant transactions. The primary non-derivative transaction is detailed below.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-16 |
| Transaction Code | A (Award) |
| Security Type | CACI Common Stock |
| Shares Involved | 53 |
| Price Per Share | $0.00 (Grant) |
| Total Value | ~$27,332 |
| Shares Owned After | 1,987 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
The analysis considers the combined value of the 53 common shares and the 492 RSUs granted on the same day.
| Metric | Value |
|---|---|
| Total Transaction Value | ~$281,052 |
| % of Market Cap | 0.0025% |
| Total Shares Transacted | 545 (53 stock + 492 RSUs) |
| % of Shares Outstanding | 0.0025% |
| Post-Transaction Ownership | 1,987 shares (0.009% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with an $11.34 billion market cap, a total grant value of ~$281k is standard procedure for board compensation and is financially immaterial.
- Ownership Concentration: The insider's post-transaction holding of 1,987 shares represents a very small fraction (0.009%) of the total shares outstanding, indicating low ownership concentration from this individual.
- Dilution Impact: The 545 shares (common stock and underlying RSUs) represent 0.0025% of shares outstanding. This is a negligible dilution impact for existing shareholders.
- Transaction Significance: Based on the transaction's value being significantly less than 0.1% of the market cap and the shares involved being less than 0.1% of shares outstanding, the transaction's significance is low.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The market generally does not react to routine, scheduled equity grants to directors as they are part of a predictable compensation structure and do not signal new information about the company's future prospects.
Volume & Sentiment
- Expected Volume Impact: Negligible. This type of filing does not typically drive trading volume.
- Sentiment Indicator: Neutral. This is a standard corporate governance event, not a bullish or bearish signal.
Investment Insights
Positive Market Indicators
- Equity-based compensation aligns the interests of the Board Chair with those of shareholders.
Risk Factors
- No risk factors are indicated by this filing.
Key Takeaways
- This Form 4 filing details a routine annual equity grant to the Chair of the Board.
- The transaction value and share amount are immaterial relative to CACI's market capitalization and shares outstanding.
- The event has a low trading significance and is not an indicator of a change in the company's fundamentals or insider sentiment.
Additional Context
Transaction Notes
- The filing included two grants: 53 shares of common stock as part of the annual retainer for the Chair of the Board, and a separate grant of 492 Restricted Stock Units (RSUs).
- The 492 RSUs vest in four equal installments quarterly throughout the following year, starting in January 2026.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
